| [1］Cillóniz C，Ewig S，PolverinoE，et al.Microbial aetiology of community-acquired pneumonia and its relation to severity［J］.Thorax，2011，66(4)：3403-3406. [2］Tao LL，Hu BJ，He LX，et al.Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China［J］.Chin Med J(Engl)，2012，125：2967-2972. [3］Okazaki N，Narita M，Yamada S，et al.Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro［J］.MicrobiolImmunol，2001，45(8)：617-620. [4］Zhao F，Liu G，Wu J，et al.Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing，China，from 2008 to 2012［J］.Antimicrob Agents Chemother，2013，57(3)：1521-1523. [5］Cao B，Zhao CJ，Yin YD，et al.High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China［J］.Clin Infect Dis，2010，51(2)：189-194. [6］Lucier TS，Heitzman K，Liu SK，et al.Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumonia［J］.Antimicrob Agents Chemother，1995，39(12)：2770-2773. [7］Averbuch D，Hidalgo-Grass C，Moses AE，et al.Macrolide resistance in Mycoplasma pneumoniae，Israel，2010［J］.Emerg Infect Dis，2011，17(6)：1079-1082. [8］Eshaghi A，Memari N，Tang P，et al.Macrolide-resistant Mycoplasma pneumoniae in humans，Ontario，Canada，2010-2011［J］.Emerg Infect Dis，2013，19(9). [9］Zhou Y，Zhang Y，Sheng Y，et al.More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniaepneumonia［J］.Antimicrob Agents Chemother，2014，58(2)：1034-1038. |
